Ven Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 29-07-2024
- Paid Up Capital ₹ 9.60 M
as on 29-07-2024
- Company Age 15 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 12.82 Cr
as on 29-07-2024
- Revenue -21.55%
(FY 2023)
- Profit -23.42%
(FY 2023)
- Ebitda -11.58%
(FY 2023)
- Net Worth 24.72%
(FY 2023)
- Total Assets 4.38%
(FY 2023)
About Ven Biotech
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 9.60 M.
The company currently has active open charges totaling ₹12.82 Cr.
Venugopal and Padmaja Venugopal serve as directors at the Company.
- CIN/LLPIN
U24232TN2009PTC071115
- Company No.
071115
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Mar 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Ven Biotech Private Limited offer?
Ven Biotech Private Limited offers a wide range of products and services, including Cooking Spices and Masala, Whole Spices, Ayurvedic Pain Relief Oil, Muscle Pain Oil, Flavours & Aromatics, Food Stabilizer, Dietary Supplements, L-Carnitine Base Powder, Ayurvedic Herbal Syrups & Tonics, Ayurvedic Health Tonic.
Who are the key members and board of directors at Ven Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Padmaja Venugopal  | Managing Director | 25-Mar-2009 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Venugopal | Whole-Time Director | 25-Mar-2009 | Current |
Financial Performance of Ven Biotech.
Ven Biotech Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 21.55% decrease. The company also saw a substantial fall in profitability, with a 23.42% decrease in profit. The company's net worth Soared by an impressive increase of 24.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ven Biotech?
In 2023, Ven Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 17 Jun 2020 | ₹5.15 M | Open |
Others Creation Date: 05 May 2020 | ₹6.30 Cr | Open |
Others Creation Date: 26 Sep 2013 | ₹6.00 Cr | Open |
How Many Employees Work at Ven Biotech?
Ven Biotech has a workforce of 15 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ven Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ven Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
